IFNG and colorectal cancer: Thus, loss of optineurin impairs the integrity of the IFNγ- and MHC-I-signaling pathways via IFNGR1 degradation, thereby driving immune evasion and intrinsic immunotherapy resistance in colorectal cancer [69] (Fig. 3).